by Dr. Stephen Parker (Article selection and Commentary) on May 12, 2013
Possible Reason for Cholesterol-Drug Side Effects Such as Memory Loss May 10, 2013 — The U.S. Food and Drug Administration and physicians continue to document that some patients experience fuzzy thinking and memory loss while taking statins, a class of global top-selling cholesterol-lowering drugs. Share This: 139 A University of Arizona research team has made [...]
by Dr. Stephen Parker (Article selection and Commentary) on August 11, 2011
(As has been mentioned before, in my opinion Cardiologist Richard Fogoros publishes the most medically reliable heart information on the Web..) My own experience with statins is that all of them had side effects of muscle weakness and pain…. For months I attributed it to an exercise program, but by gong to such sites as [...]
by Dr. Stephen Parker (Article selection and Commentary) on February 20, 2011
40-Point Cholesterol Drop=20% Lower Heart Risk Heart Disease Protection Tied to Cholesterol Reduction Achieved With Drugs WebMD Health News Sept. 27, 2005 — The heart disease protection offered by popular cholesterol-lowering statin drugs may be directly related to the degree they actually lower a person’s cholesterol levels. A new review of studies on statins shows [...]
by Dr. Stephen Parker (Article selection and Commentary) on February 20, 2011
From the article: Although some statins are stronger than others, there’s no evidence that one is better than another at preventing heart attacks or other cardiovascular outcomes. National guidelines on lowering cholesterol treat the statins as equivalent. A study from the Boston VA Healthcare System supports this approach. Veterans who achieved the greatest reduction in [...]
by Dr. Stephen Parker (Article selection and Commentary) on October 13, 2010
by Dr. Stephen Parker (Article selection and Commentary) on August 13, 2010
Brilliant idea. Let’s also put statins in the drinking water. Outlets Should Offer Free Statins With Junk Food Say UK Researchers MedPage Today 13 Aug 2010 Imagine this: order a cheeseburger and fries, and pick up a free cholesterol-busting statin tablet along with the other free condiments, that’s what a group of UK researchers suggests [...]
by Dr. Stephen Parker (Article selection and Commentary) on June 9, 2010
from: Cardiology Blog, Alegent Health Care June 6, 2010 There is no class of medications in the history of the world that has been better studied that statins. This class of drugs is more properly termed HMG CoA reductase (3-hydroxy-3-methyl-glutaryl co-enzyme A reductase) inhibitors, but with a name like that a terser nickname is almost [...]
by Dr. Stephen Parker (Article selection and Commentary) on April 13, 2010
Statin drugs, or HMG-CoA reductase inhibitors, are a class of drugs used to lower cholesterol. Statins work by inhibiting the enzyme HMG-CoA reductase, the enzyme that determines the rate of cholesterol formation. Some research suggests that statin drugs may interfere with the body’s production of Co q10, a substance produced naturally in the body and [...]
by Dr. Stephen Parker (Article selection and Commentary) on April 1, 2010
From the very onset of use of statin drugs for their powerful cholesterol lowering effect, muscle aches and pains reflecting possible underlying muscle inflammation was anticipated and, indeed, were listed in the Physician’s Desk Reference for every practitioner in the land. The relatively low frequency of muscle inflammation was felt to be an acceptable burden [...]
by Dr. Stephen Parker (Article selection and Commentary) on March 31, 2010
With the government’s blessing, a drug giant is about to expand the market for its blockbuster cholesterol medication Crestor to a new category of customers: as a preventive measure for millions of people who do not have cholesterol problems. Some medical experts question whether this is a healthy move. They point to mounting concern that [...]
by Dr. Stephen Parker (Article selection and Commentary) on March 29, 2010
Even under high magnification, new drug benefits are vanishing By the end of the 20th century, modern medicine was fending off 190,000 deaths a year from otherwise fatal heart conditions. Funding poured into cardiovascular research, more than doubling from $3.8b in 1995 to $8.4b in 2005. Now from this richly oxygenated drug pipeline, two new [...]
by heartcurrents on March 17, 2010
Click Here: Emedicine Comment: Very well done and un-biased slideshow. Someone spent a lot of time organizing and getting the right photographs.